Senseonics (NYSE:SENS) shares ticked up today on fourth-quarter results that came in ahead of the consensus forecast.
The Germantown, Maryland-based company posted revenues of $4 million for the three months ended Dec. 31, 2021, representing sales growth of 2.6% from the same period in 2020.
Get the full story at our sister site, Drug Delivery Business News.